KiLee(Lee)MilliganMD

Executive Director, Pediatric Center of Excellence, Global Drug Development, Novartis

Dr. Milligan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Novartis Pharmaceuticals, Respiratory Medical Affairs, Tokyo, Japan
Guest Researcher with NIAID, National Institutes of Health
Washington, DC 20016

National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 2013 - 2016
SSM Health/Saint Louis University School of MedicineResidency, Pediatrics, 2009 - 2012
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineInternship, Transitional Year, 2001 - 2002
UniforMed Services University of the Health Sciences F. Edward Hebert School of MedicineClass of 2001

PubMed

6 citations
Ataxia telangiectasia associated with nodular regenerative hyperplasia.
Ki Lee Milligan, Karen Schirm, Stephanie A. Leonard, Ashleigh A. Hussey, Anahita Agharahimi
Journal of Clinical Immunology. 2016-09-26
3 citations
Ataxia telangiectasia presenting as hyper IgM syndrome without neurologic signs.
Ashmi Doshi, Julie Ryu, Courtney D. Thornburg, Daniel Hershey, Rebecca Cherry
Annals of Allergy, Asthma & Immunology. 2016-09-01
44 citations
Endemic mycoses in patients with STAT3-mutated hyper-IgE (Job) syndrome
Camila D. Odio, Ki Lee Milligan, Katherine McGowan, Amanda K. Rudman Spergel, Rachel Bishop
The Journal of Allergy and Clinical Immunology. 2015-11-01